Mel-Mont Medical key facts
- Developer of advanced molecular diagnostics intended for the early detection and prevention of RNA-virus-related pathologies.
- It has raised $11.0M across 3 recorded rounds; the latest was Seed Round ($250K) in Dec 2025.
- Mel-Mont Medical has filed 3 Form Ds with the SEC since 2020, most recently Dec 2025 ($250K sold to 3 investors).
- Status: Privately Held (backing).
- ·Watch Mel-Mont Medical: the Monday email on marks, rounds and moves
Mel-Mont Medical funding rounds
3 roundsHow much has Mel-Mont Medical raised?
Mel-Mont Medical has raised $11 million across 3 recorded rounds since 2020. The largest was a $6.9 million early-stage round in Aug 2023; the most recent was a $250,000 seed round in Dec 2025.
Mel-Mont Medical has filed 3 Form Ds with the SEC since 2020, most recently in Dec 2025 ($250,000 sold to 3 investors).
About Mel-Mont Medical
Developer of advanced molecular diagnostics intended for the early detection and prevention of RNA-virus-related pathologies. The company's platform utilizes patented and clinically proven technologies to identify high-risk human papillomavirus and respiratory viruses, enabling healthcare providers to enhance patient outcomes through timely interventions and improved disease management strategies.
- Sector
- Healthcare
- HQ
- Doral, FL, United States
- Founded
- 2014
- Employees
- 4
- Website
- mel-montmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.
Mel-Mont Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.